Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans

Stefan, Norbert, Häring, Hans-Ulrich·2013·Nature Medicine
DOI 10.1038/nm.3116

Cited by (159)

Items 101–159 of 159

  1. Sialylated Fetuin-A as a candidate predictive biomarker for successful grass pollen allergen immunotherapy
    Noémie Caillot, Julien Bouley, Karine Jain, Sandrine Mariano, Sonia Luce, Stéphane Horiot, Sabi Airouche, Chloé Beuraud, Christian Beauvallet, Philippe Devillier et al. · 2016 · Journal of Allergy and Clinical Immunology
  2. Mechanisms Explaining the Relationship Between Metabolically Healthy Obesity and Cardiovascular Risk
    Norbert Stefan, Andreas Fritsche, Hans‐Ulrich Häring · 2014 · Journal of the American College of Cardiology
  3. Proteomics analyses of acute kidney injury biomarkers in a rat exertional heat stroke model
    Fuli Wen, Yongjun Xu, Lai-En Xue, Yunfeng Fu, Lin-Lin Cui, Jun-Zhu Wang, Heping Zheng, Dong‐Hui Zhou, Jun Lu · 2023 · Frontiers in Physiology
  4. A rapid sandwich immunoassay for human fetuin A using agarose-3-aminopropyltriethoxysilane modified microtiter plate
    Sandeep Kumar Vashist, E. Marion Schneider, John H. T. Luong · 2015 · Analytica Chimica Acta
  5. Fetuin-A mediates the difference in adipose tissue insulin resistance between young adult pakistani and norwegian patients with type 2 diabetes
    Sindre Lee-Ødegård, Thor Ueland, Per Medbøe Thorsby, Pål Aukrust, Annika Elisabet Michelsen, Bente Lise Halvorsen, Christian Andre Drevon, Kåre I. Birkeland · 2022 · BMC Endocrine Disorders
  6. The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients
    Michael Leutner, Christian S. Göbl, Oliver Schlager, Silvia Charwat‐Resl, Alice Wielandner, Eleonora Howorka, Marlies Prünner, Latife Bozkurt, Katharina Maruszczak, Hacer Geyik et al. · 2017 · Journal of the American College of Nutrition
  7. The role of fetuin-A in cardiovascular diseases
    Krisztián Vörös, Károly Cseh, László Kalabay · 2013 · Orvosi Hetilap
  8. Alterations of Serum Ser312‐Phosphorylated Fetuin‐A from Exercise‐Induced Moderate Body Weight Loss in Individuals with Obesity
    Guang Ren, Robert L. Bowers, Teayoun Kim, Felipe Araya-Ramírez, A. Jack Mahurin, David M. Dean, Peter W. Grandjean, Suresh T. Mathews · 2020 · Obesity
  9. Preclinical and clinical obesity: prevalence, associations to cardiometabolic risk and response to lifestyle intervention in NHANES and the EPIC-Potsdam and TULIP studies
    Catarina Schiborn, Frank B. Hu, Norbert Stefan, Matthias Bernd Schulze · 2026 · Nature Communications
  10. Detection and Characterization of Phosphorylation, Glycosylation, and Fatty Acid Bound to Fetuin A in Human Blood
    Markéta Kovářová, Hubert Kalbacher, Andreas Peter, Hans‐Ulrich Häring, Triantafyllos Didangelos, Norbert Stefan, Andreas L. Birkenfeld, Erwin D. Schleicher, Kοnstantinos Kantartzis · 2021 · Journal of Clinical Medicine
  11. Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Premenopausal Women with Metabolic Syndrome
    Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Omnia State, Rasha Rizk Elzehery, Ahmed Salem Mohamed · 2021 · Hormone and Metabolic Research
  12. Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics
    Jingjing Jiao, Suet‐Ying Kwan, Caroline M. Sabotta, Honami Tanaka, Lucas J. Veillon, Marc O. Warmoes, Philip L. Lorenzi, Ying Wang, Peng Wei, Ernest T. Hawk et al. · 2021 · Cancer Epidemiology Biomarkers & Prevention
  13. Human Fetuin-A Rs4918 Polymorphism and its Association with Obesity in Healthy Persons and in Patients with Myocardial Infarction in Two Hungarian Cohorts
    György Temesszentandrási, Krisztián Vörös, Bernadett Márkus, Zoltán Böröcz, Edit Kaszás, Zoltán Prohászka, András Falus, Károly Cseh, László Kalabay · 2016 · Medical Science Monitor
  14. Changes in Liver Gene Expression and Plasma Concentration of Rbp4, Fetuin-A, and Fgf21 in Sprague-Dawley Rats Subjected to Different Dietary Interventions and Bariatric Surgery
    Dominika Marta Stygar, Wojciech Pigłowski, Elżbieta Chełmecka, Bronisława Skrzep-Poloczek, Tomasz Sawczyn, Wojciech Garłowski, Jerzy Jochem, Konrad Wojciech Karcz · 2018 · BioMed Research International
  15. Lipocalin 13 enhances insulin secretion but is dispensable for systemic metabolic control
    Lea Bühler, Adriano Maida, Elena Sophie Vogl, Anastasia Georgiadi, Andrea Takacs, Oliver Kluth, Annette Schürmann, Annette Feuchtinger, Christine von Toerne, Foivos‐Filippos Tsokanos et al. · 2021 · Life Science Alliance
  16. Determinants of hepatic insulin clearance – Results from a Mendelian Randomization study
    Apostolia Lamprinou, Caroline Willmann, Jürgen Machann, Fritz Schick, Sabine S. Eckstein, Chiara Dalla Man, ROBERTO VISENTIN, Andreas L. Birkenfeld, Andreas Peter, Norbert Stefan et al. · 2021 · Metabolism
  17. Adipose Tissue Insulin Resistance in South Asian and Nordic Women after Gestational Diabetes Mellitus
    A Anita Suntharalingam, Archana Sharma, Christine Sommer, Elisabeth Qvigstad, Hanne Løvdal Gulseth, Stina Therese Sollid, Ingrid Nermoen, Naveed A. Sattar, Jason M. R. Gill, Tone Møller Tannæs et al. · 2024 · Metabolites
  18. Common genetic variants in the FETUB locus, genetically predicted fetuin-B levels, and risk of insulin resistance in obese Chinese adults
    Zhibin Li, Changqin Liu, Xiulin Shi, Zhen Chen, Dongmei Wang, Long Li, Yichang Tu, Mingzhu Lin, Suhuan Liu, Shuyu Yang et al. · 2017 · Medicine
  19. FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation
    Deborah Mattinzoli, Masami Ikehata, Koji Tsugawa, Carlo Alfieri, Mario Barilani, Lorenza Lazzari, Paola Andreetta, Francesca Marta Elli, Giovanna Mantovani, Piergiorgio Messa · 2019 · International Journal of Molecular Sciences
  20. The association between cardiac valvular calcification and fetuin-A levels in kidney transplant recipients
    Nizameddin Koca, Alparslan Ersoy, Barış Şensoy, Emine Kırhan, Sümeyye Güllülü, Canan Ersoy, Melahat Dirican, Emre Sarandöl · 2019 · Clinical and Experimental Nephrology
  21. Usefulness of Fetuin-A to Predict Risk for Cardiovascular Disease Among Patients With Obstructive Sleep Apnea
    Alice Liu, Cindy A. Lamendola, Danit Ariel, Fahim Abbasi, Sun H. Kim, James A. Cardell, Vanessa Tomasso, Shiming Xu, Shailja Patel, Hafasa Mojaddidi et al. · 2015 · The American Journal of Cardiology
  22. Proposed cut-off value of the intrahepatic lipid content for metabolically normal persons assessed by proton magnetic resonance spectroscopy in a Japanese population
    Fumiaki Matsubara, Yoshio Nagai, Hidekazu Tsukiyama, Hiroyuki Shimizu, Eigoro Yamanouchi, Teruaki Iwamoto, Yukiyoshi Sada, Hiroyuki Kato, Akio Ohta, Yasushi Tanaka · 2016 · Diabetes Research and Clinical Practice
  23. The application of post-translational modification oriented serum proteomics to assess experimental diabetes with complications
    Han-Min Chen, Lin-Chien Lee, Kuang-Yu Hu, Wei‐Jern Tsai, Cheng Huang, Hui-Jen Tsay, Hui‐Kang Liu · 2018 · PLoS ONE
  24. Role of Fetuin-A and vascular endothelial growth factor In type 2 diabetes mellitus patients without and with retinopathy
    Ezhumalai Priya, Kuppuswami Jayashree, Gandhipuram Periyasamy Senthilkumar, Md Yasir, Ramesh Babu K, Thiyagarajan Durga Devi · 2019 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  25. PEDF Overexpression Ameliorates Cardiac Lipotoxicity in Diabetic Cardiomyopathy via Regulation of Energy Metabolism
    Tuohua Mao, Wang Ye · 2025 · Diabetes Metabolic Syndrome and Obesity
  26. Functional Status of Pancreatic α and β Cells in Type 2 Diabetes Mellitus Patients with Different Plasma Triglyceride Levels: A Retrospective Analysis
    Hang Guo, Chunlei Ma, Xiaoming Wu, Congqing Pan · 2021 · International Journal of Endocrinology
  27. Interaction of fetuin-A with obesity related insulin resistance and diabetes mellitus
    Yıldız Öner-İyidoğan, Hikmet Koçak · 2024 · Turkish Journal of Biochemistry
  28. Association of PPAR Alpha Intron 7 G/C, PPAR Gamma 2 Pro12Ala, and C161T Polymorphisms with Serum Fetuin-A Concentrations
    Bernadett Márkus, Krisztián Vörös, Dorina Supák, Zsolt Melczer, Károly Cseh, László Kalabay · 2017 · PPAR Research
  29. Relationship of Serum Fetuin A with Metabolic and Clinical Parameters in German Children and Adolescents with Type 1 Diabetes
    Christina Reinauer, Thomas Reinehr, Christina Bächle, Beate Karges, Julia Seyfarth, Katharina Foertsch, Martin Schebek, Joachim Woelfle, Michael Roden, Reinhard Walter Holl et al. · 2017 · Hormone Research in Paediatrics
  30. Hepatocyte-derived Fetuin-A promotes alcohol-associated liver disease in mice by inhibiting autophagy-lysosome degradation of TLR and M2 macrophage polarization
    Shibang Lu, Jin Hu, Tiantian Nong, Dongxiao Li, Kang Long, Yanjun Chen, Yan Li, Hao Xing, Tingcai Pan, Songqing He et al. · 2024 · Free Radical Biology and Medicine
  31. The evolving roles of fetuin-A in type 2 diabetes mellitus and its potential clinical implications: a review
    Mohammed Jemal, Nuredin Chura Waritu, Temesgen Baylie, Deresse Sinamaw, Enyew Fenta Mengistu, Enatnesh Essa Osman, Gelagey Baye, Bantayehu Addis Tegegne, Gashaw Azanaw Amare, Zigale Hibstu Teffera et al. · 2025 · Therapeutic Advances in Chronic Disease
  32. Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes
    Andressa Coope, Adriana Souza Torsoni, Licio Augusto Velloso · 2016 · European Journal of Endocrinology
  33. Larger omental adipocytes correlate with greater Fetuin-A reduction following sleeve gastrectomy
    Katie N. Robinson, Blair M. Rowitz, Uretz J. Oliphant, Sharon Marie Donovan, Margarita Terán-Garcı́a · 2019 · BMC Obesity
  34. Different Metabolic Responses to Long-term Weight Loss After Lifestyle Intervention Among Type 2 Diabetes Risk Clusters: Results From the TULIP Study
    Caroline Z. Meier, Robert Wagner, Marlene Ganslmeier, Kοnstantinos Kantartzis, Martin Heni, Andreas Peter, Reiner Jumpertz von Schwartzenberg, Jürgen Machann, Fritz Schick, Andreas L. Birkenfeld et al. · 2026 · Diabetes
  35. Iron overload in steatotic hepatocytes drives systemic metabolic dysfunction via alterations in hepatokine production
    Hye Jin Jo, Ayoung Kim, Hyunsoo Rho, Ae Kyung Park, Gil-Hwan Kim, Seo Jeong Jo, Hao Yuxin, You-Jung Hong, Ji Min Yeon, Hwang Chan Yu et al. · 2026 · Journal of Clinical Investigation
  36. A comprehensive review on the mechanistics of free fatty acid-induced insulin resistance and it’s therapeutics: Molecular perspectives
    Swati Banerjee, Subhajit Maity, Subhajit Ghosh, Arunodaya Gautam, Indrani Chakraborty, Nabin Baran Manik · 2026 · Prostaglandins & Other Lipid Mediators
  37. Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification
    Norbert Stefan · 2016 · Clinical Gastroenterology and Hepatology
  38. Phenotypes of prediabetes: pathogenesis and consequences for prediction and prevention of type 2 diabetes and cardiovascular diseases
    Norbert Stefan · 2020 · Diabetes Mellitus
  39. Role of the Genetic Variants of Fetuin-A and Adiponectin in Type 2 Diabetes Mellitus: A Narrative Review
    Huma Khan, Vishal Parmar, Mohammad Mustufa Khan, Saba Khan, Roshan Alam · 2025 · Cureus
  40. Fetuin‐b Mediates Lipid Overload‐Induced Hepatic Lipid Accumulation in Large Yellow Croaker ( Larimichthys crocea )
    Yanan Shen, Qiuchi Chen, Zengqi Zhao, Qiang Chen, Yuhang Tang, Fan Chen, Tingting Hao, Jianlong Du, Qinghui Ai · 2026 · The FASEB Journal
  41. Insulin Resistance as a Systemic Metabolic Risk State for Cancer: Mechanisms, Biomarkers, and Prevention
    Marijana Matek Sarić, Nataša Lisica Šikić, Tamara Sorić, Ana Sarić, Andrija Ivanišin, Ivona Brodić, Mirta Milić · 2026 · International Journal of Molecular Sciences
  42. Response to Article “Effect of Helicobacter Pylori Infection on Glucose Metabolism, Lipid Metabolism and Inflammatory Cytokines in Nonalcoholic Fatty Liver Disease Patients” [Letter]
    Putu Yuliandari, I Putu Bayu Mayura · 2024 · Journal of Multidisciplinary Healthcare
  43. Biomarkers of Insulin Resistance
    Kimberly A. Cox‐York, Rocio I. Pereira · 2019 · Contemporary Endocrinology
  44. Toll-like Rezeptor 4 als gemeinsamer Regulator von Energiestoffwechsel und Inflammation bei der Pathogenese des Insulinmangeldiabetes im Tiermodell der non-obese diabetic Maus
    Anna Lena Reinbeck · 2013 · Univ. Duesseldorf: Duesseldorfer Dokumenten- und Publikationsserver
  45. Role of phosphorylated fetuin-A in insulin action, insulin resistance, obesity, and moderate weight loss
    Guang Ren · 2014
  46. 4.1 Pathogenese des Diabetes mellitus Typ 2 - 109 4.2 Die Rolle der Mitochondrien bei Diabetes mellitus - 113 4.3 Postprandiale Hyperglykämie, subklinische Inflammation und endotheliale Dysfunktion - 115 4.4 Übergewicht und metabolisches Syndrom - 122
    Hermann P. T. Ammon, Andre Burchard, Heinz Drexel, Martin Füchtenbusch, Hans Hauner, Stephan Matthaei, Martin Merkel, Dirk Müller‐Wieland, Martin Pfohl, Michael Roden et al. · 2014
  47. Serum Level of Cytokeratin-18/M30 Antigen is Increased in the Cases with Impaired Glucose Tolerance
    Şölen Himmetoğlu, Selin Yüksel, Taner Damcı, Ilkova Hasan, Dincer Yildiz · 2017 · International Archives of Endocrinology Clinical Research
  48. L'insulinorésistance chez l'homme : des mécanismes aux interventions nutritionnelles
    Ariane Sultan · 2017 · Biologie Aujourd hui
  49. Fetuin-A: a novel marker for obesity and associated comorbidities
    Katie N. Robinson · 2017 · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
  50. No Independent Association of Circulating Fetuin-A with Insulin Sensitivity in Young Women
    S. Reif, Sarah Moschko, Christina Gar, Uta Ferrari, Nina Hesse, Nora Navina Sommer, Jochen Seißler, Andreas Lechner · 2020 · Hormone and Metabolic Research
  51. Fettleber und Diabetes: Pathomechanismen
    Norbert Stefan · 2020 · Der Diabetologe
  52. Typ-2-Diabetes
    Hermann P. T. Ammon, Andre Burchard, Heinz Drexel, Martin Füchtenbusch, Hans‐Ulrich Häring, Hans Hauner, Hans‐Georg Joost, Stephan Matthaei, Martin Merkel, Dirk Müller‐Wieland et al. · 2014 · Springer eBooks
  53. Fetuin-A Concentration in the Perinatal Period and Maternal BMI Dynamics During Pregnancy, Labor, and Early Postpartum: Is ΔBMI a Parameter Worth Considering?
    Aleksandra Obuchowska, Żaneta Kimber-Trojnar, Monika Czuba, Katarzyna Trojnar, Bożena Leszczyńska‐Gorzelak · 2025 · Journal of Clinical Medicine
  54. Additional file 1 of Serum free fatty acids are associated with severe coronary artery calcification, especially in diabetes: a retrospective study
    Yangxun Xin, Zhang, Junfeng, Fan, Yuqi, Changqian Wang · 2021 · Figshare
  55. Rôle des mécanismes régulateurs de l'inflammation dans le développement de l'insulinorésistance chez des sujets obèses sans comorbidités associées
    Cacylde Amouzou · 2016 · theses.fr (ABES)
  56. Rôle de LECT2 dans les maladies stéatosiques non alcooliques du foie
    Sandrine Pham · 2020 · theses.fr (ABES)
  57. Pathophysiologie der mit metabolischer Dysfunktion assoziierten steatotischen Lebererkrankung
    Kοnstantinos Kantartzis · 2026 · Die Diabetologie
  58. Fetuin-A Induced Suppression of PPAR Signaling: Molecular Insights and the Potential Regulatory Role of Fucosylation
    Yıldız Öner-İyidoğan, Hikmet Koçak · 2026 · Cells
  59. Metabolic Regulation by Adipokines, Hepatokines, and Myokines
    Norbert Stefan, Morris F. White, Hans‐Ulrich Häring · 2026 · Elsevier eBooks